Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$1.13 - $3.69 $3,159 - $10,317
-2,796 Reduced 3.59%
75,188 $113,000
Q1 2022

May 09, 2022

BUY
$2.85 - $3.73 $37,605 - $49,217
13,195 Added 20.37%
77,984 $257,000
Q4 2021

Feb 07, 2022

BUY
$3.24 - $5.18 $2,854 - $4,563
881 Added 1.38%
64,789 $218,000
Q3 2021

Oct 28, 2021

BUY
$3.94 - $5.84 $60,033 - $88,984
15,237 Added 31.31%
63,908 $325,000
Q2 2021

Aug 13, 2021

SELL
$4.26 - $6.5 $10,624 - $16,211
-2,494 Reduced 4.87%
48,671 $213,000
Q1 2021

May 06, 2021

SELL
$5.03 - $8.8 $114,341 - $200,041
-22,732 Reduced 30.76%
51,165 $318,000
Q4 2020

Feb 12, 2021

SELL
$4.04 - $5.31 $190,122 - $249,888
-47,060 Reduced 38.91%
73,897 $361,000
Q3 2020

Nov 06, 2020

BUY
$3.64 - $7.76 $191,183 - $407,578
52,523 Added 76.75%
120,957 $509,000
Q2 2020

Jul 29, 2020

BUY
$4.78 - $8.26 $79,233 - $136,917
16,576 Added 31.96%
68,434 $474,000
Q1 2020

May 14, 2020

BUY
$4.0 - $21.53 $103,220 - $555,581
25,805 Added 99.05%
51,858 $207,000
Q4 2019

Feb 07, 2020

SELL
$13.94 - $24.12 $251,087 - $434,449
-18,012 Reduced 40.88%
26,053 $559,000
Q3 2019

Nov 12, 2019

BUY
$13.89 - $23.16 $190,334 - $317,361
13,703 Added 45.13%
44,065 $668,000
Q2 2019

Aug 12, 2019

BUY
$16.27 - $20.51 $100,141 - $126,239
6,155 Added 25.43%
30,362 $588,000
Q1 2019

May 15, 2019

BUY
$12.61 - $22.33 $122,354 - $216,667
9,703 Added 66.9%
24,207 $503,000
Q4 2018

Feb 01, 2019

SELL
$12.41 - $22.98 $31,285 - $57,932
-2,521 Reduced 14.81%
14,504 $197,000
Q3 2018

Nov 09, 2018

BUY
$2.45 - $16.27 $7,648 - $50,794
3,122 Added 22.46%
17,025 $277,000
Q2 2018

Aug 10, 2018

BUY
$2.68 - $3.48 $37,260 - $48,382
13,903 New
13,903 $43,000
Q1 2018

May 04, 2018

SELL
$2.99 - $4.44 $40,388 - $59,975
-13,508 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$3.06 - $4.09 $41,334 - $55,247
13,508
13,508 $54,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $254M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.